DNA strand asymmetry generated by CpG hemimethylation has opposing effects on CTCF binding.

Autor: Thomas SL; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI 49503, USA., Xu TH; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI 49503, USA.; Department of Structural Biology, Van Andel Institute, Grand Rapids, MI 49503, USA., Carpenter BL; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI 49503, USA., Pierce SE; Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, USA., Dickson BM; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI 49503, USA., Liu M; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI 49503, USA., Liang G; Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA., Jones PA; Department of Epigenetics, Van Andel Institute, Grand Rapids, MI 49503, USA.

Publikováno v: Nucleic acids research [Nucleic Acids Res] 2023 Jul 07; Vol. 51 (12), pp. 5997-6005.

The human IL-15 superagonist N-803 promotes migration of virus-specific CD8+ T and NK cells to B cell follicles but does not reverse latency in ART-suppressed, SHIV-infected macaques.

Autor: Webb GM; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Molden J; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America., Busman-Sahay K; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Abdulhaqq S; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Wu HL; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Weber WC; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Bateman KB; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Reed JS; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Northrup M; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Maier N; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Tanaka S; ImmunityBio, Los Angeles, California, United States of America., Gao L; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Davey B; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America., Carpenter BL; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America., Axthelm MK; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America., Stanton JJ; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Smedley J; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Greene JM; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Safrit JT; NantKWest, Los Angeles, California, United States of America., Estes JD; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Skinner PJ; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America., Sacha JB; Vaccine & Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.

Publikováno v: PLoS pathogens [PLoS Pathog] 2020 Mar 12; Vol. 16 (3), pp. e1008339. Date of Electronic Publication: 2020 Mar 12 (Print Publication: 2020).

Physalis Mottle Virus-Like Particles as Nanocarriers for Imaging Reagents and Drugs.

Autor: Masarapu H; Department of Virology, Sri Venkateswara University , Tirupati, 517 502 Andhra Pradesh, India., Patel BK, Chariou PL, Hu H, Gulati NM, Carpenter BL; Department of Chemistry, North Carolina State University , Raleigh, North Carolina 27695, United States., Ghiladi RA; Department of Chemistry, North Carolina State University , Raleigh, North Carolina 27695, United States., Shukla S, Steinmetz NF

Publikováno v: Biomacromolecules [Biomacromolecules] 2017 Dec 11; Vol. 18 (12), pp. 4141-4153. Date of Electronic Publication: 2017 Nov 16.

S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide.

Autor: Stewart RL; Markey Cancer Center, University of Kentucky, Lexington, KY 40506, USA.; Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY 40506, USA., Carpenter BL; Markey Cancer Center, University of Kentucky, Lexington, KY 40506, USA.; Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40506, USA., West DS; Department of Pathology and Laboratory Medicine, University of Kentucky, Lexington, KY 40506, USA., Knifley T; Markey Cancer Center, University of Kentucky, Lexington, KY 40506, USA., Liu L; Department of Toxicology, Guangdong Province Hospital for Occupational Disease Prevention and Treatment, Guangzhou, Guangdong, 510300, PR China., Wang C; Markey Cancer Center, University of Kentucky, Lexington, KY 40506, USA.; Department of Biostatistics, University of Kentucky, Lexington, KY 40506, USA., Weiss HL; Markey Cancer Center, University of Kentucky, Lexington, KY 40506, USA.; Department of Biostatistics, University of Kentucky, Lexington, KY 40506, USA., Gal TS; Markey Cancer Center, University of Kentucky, Lexington, KY 40506, USA.; Division of Biomedical Informatics, University of Kentucky, Lexington, KY 40506, USA., Durbin EB; Markey Cancer Center, University of Kentucky, Lexington, KY 40506, USA.; Division of Biomedical Informatics, University of Kentucky, Lexington, KY 40506, USA., Arnold SM; Markey Cancer Center, University of Kentucky, Lexington, KY 40506, USA., O'Connor KL; Markey Cancer Center, University of Kentucky, Lexington, KY 40506, USA.; Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40506, USA., Chen M; Markey Cancer Center, University of Kentucky, Lexington, KY 40506, USA.; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, KY 40506, USA.

Publikováno v: Oncotarget [Oncotarget] 2016 Jun 07; Vol. 7 (23), pp. 34630-42.

High Aspect Ratio Nanotubes Formed by Tobacco Mosaic Virus for Delivery of Photodynamic Agents Targeting Melanoma.

Autor: Lee KL; Department of Biomedical Engineering, Schools of Medicine and Engineering, Case Western Reserve University, Cleveland, Ohio 44106, United States., Carpenter BL; Department of Chemistry, North Carolina State University, Raleigh, North Carolina 27695, United States., Wen AM; Department of Biomedical Engineering, Schools of Medicine and Engineering, Case Western Reserve University, Cleveland, Ohio 44106, United States., Ghiladi RA; Department of Chemistry, North Carolina State University, Raleigh, North Carolina 27695, United States., Steinmetz NF; Department of Biomedical Engineering, Schools of Medicine and Engineering, Case Western Reserve University, Cleveland, Ohio 44106, United States.; Department of Radiology, Schools of Medicine and Engineering, Case Western Reserve University, Cleveland, Ohio 44106, United States.; Department of Materials Science and Engineering, Schools of Medicine and Engineering, Case Western Reserve University, Cleveland, Ohio 44106, United States.; Department of Macromolecular Science and Engineering, Schools of Medicine and Engineering, Case Western Reserve University, Cleveland, Ohio 44106, United States.; Case Comprehensive Cancer Center, Schools of Medicine and Engineering, Case Western Reserve University, Cleveland, Ohio 44106, United States.

Publikováno v: ACS biomaterials science & engineering [ACS Biomater Sci Eng] 2016 May 09; Vol. 2 (5), pp. 838-844. Date of Electronic Publication: 2016 Mar 23.